isoquercitrin has been researched along with Antiphospholipid-Syndrome* in 1 studies
1 trial(s) available for isoquercitrin and Antiphospholipid-Syndrome
| Article | Year |
|---|---|
Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation.
Topics: Administration, Oral; Animals; Antiphospholipid Syndrome; Blood Coagulation Factors; Humans; Models, Animal; Protein Disulfide-Isomerases; Quercetin; Thrombin | 2017 |